Newfound Research’s POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO XLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-52
Closed -$5K 211
2020
Q1
$5K Buy
52
+13
+33% +$1.25K 0.01% 25
2019
Q4
$5K Sell
39
-51
-57% -$6.54K ﹤0.01% 61
2019
Q3
$10K Buy
90
+59
+190% +$6.56K 0.01% 57
2019
Q2
$4K Buy
+31
New +$4K ﹤0.01% 77
2019
Q1
Sell
-35
Closed -$4K 246
2018
Q4
$4K Sell
35
-89
-72% -$10.2K ﹤0.01% 50
2018
Q3
$17K Sell
124
-33
-21% -$4.52K 0.01% 47
2018
Q2
$20K Hold
157
0.01% 32
2018
Q1
$17K Sell
157
-18
-10% -$1.95K 0.01% 40
2017
Q4
$17K Sell
175
-101
-37% -$9.81K 0.01% 58
2017
Q3
$26K Buy
276
+93
+51% +$8.76K 0.01% 48
2017
Q2
$16K Buy
183
+20
+12% +$1.75K 0.01% 56
2017
Q1
$13K Hold
163
0.01% 62
2016
Q4
$12K Hold
163
0.01% 57
2016
Q3
$12K Sell
163
-71
-30% -$5.23K 0.01% 58
2016
Q2
$17K Buy
+234
New +$17K 0.02% 53
2016
Q1
Sell
-194
Closed -$14K 71
2015
Q4
$14K Buy
+194
New +$14K 0.02% 42

Newfound Research's XLVS Position: Q2 2020 in Review

Newfound Research sold out of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) in Q2 2020, closing a stake of 52 shares — an estimated $5K sold.

Newfound Research first reported a position in XLVS in Q4 2015 and held it in 16 quarters. The position peaked at $26K in Q3 2017. 0 funds tracked by Wall St. Rank hold XLVS as of Q2 2020.

  • Newfound Research reported no remaining POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position as of Q2 2020 after selling out during the quarter.
  • Newfound Research sold 52 POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO shares in Q2 2020, an estimated $5K.
  • Newfound Research first reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in Q4 2015 and held it in 16 quarters.
  • Newfound Research's POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position peaked at $26K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.